Pivaloyl chloride → HCID 15135987, compound
Reaction equation
[Cl:1][C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][C:3]=1[C:8]1[C:14]2[CH:15]=[C:16]([CH:18]([OH:20])[CH3:19])[S:17][C:13]=2[N:12]2[C:21]([CH3:24])=[N:22][N:23]=[C:11]2[CH2:10][N:9]=1.[C:25](Cl)(=[O:30])[C:26]([CH3:29])([CH3:28])[CH3:27]>N1C=CC=CC=1>[Cl:1][C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][C:3]=1[C:8]1[C:14]2[CH:15]=[C:16]([CH:18]([O:20][C:25](=[O:30])[C:26]([CH3:29])([CH3:28])[CH3:27])[CH3:19])[S:17][C:13]=2[N:12]2[C:21]([CH3:24])=[N:22][N:23]=[C:11]2[CH2:10][N:9]=1Participants
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
To a solution of 3 g of 4-(2-chlorophenyl)-2-(1-hydroxyethyl)-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine dissolved in 30 ml of pyridine is added 1 g of pivaloyl chloride under ice-cooling and then stirred overnight. After completion of the reaction, the mixture is concentrated under reduced pressure and the residue is dissolved in 30 ml of ethyl acetate. The solution is washed with 5% aqueous sodium hydrogencarbonate solution and sodium chloride solution and dried over anhydrous magnesium sulfate. After filtering off, the filtrate is concentrated under reduced pressure and the residue is subjected to chromatography on silica gel and eluted with chloroform-methanol (100:1-100:3). The objective fraction is concentrated under reduced pressure followed by crystallization from ligroinethyl acetate to give 1.1 g of 4-(2-chlorophenyl)-9-methyl-2(1-pivaloyloxyethyl)-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine as crystals, melting at 148°-151° C.
Workup
- temperaturecooling
- customAfter completion of the reaction
- concentrationthe mixture is concentrated under reduced pressure
- dissolutionthe residue is dissolved in 30 ml of ethyl acetate
- washThe solution is washed with 5% aqueous sodium hydrogencarbonate solution and sodium chloride solution
- dry with materialdried over anhydrous magnesium sulfate
- filtrationAfter filtering off
- concentrationthe filtrate is concentrated under reduced pressure
- washeluted with chloroform-methanol (100:1-100:3)
- concentrationThe objective fraction is concentrated under reduced pressure
- customfollowed by crystallization from ligroinethyl acetate
Sources & evidence
- ORD record
- ord-fb95fc14ea0c4df2b960e9075cc3b4c8
- Source dataset
- uspto-grants-1991_07
- Patent number
- US05028603
Reaction notes
Loading…